BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9129773)

  • 1. A method for assessing catheter patency in implanted pumps for long-term intraperitoneal insulin delivery.
    Scavini M; Hammarberg B; Dosio F; Torri M; Petrella G; Galimberti G; Vai S; Fazio F; Pozza G
    Artif Organs; 1997 May; 21(5):405-8. PubMed ID: 9129773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive insulin therapy and insulin pumps.
    Bode BW
    Postgrad Med; 2002 Nov; 112(5 Suppl Designer):17-21. PubMed ID: 19667601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion.
    Rieger C; Kurz K; Mueller-Hoffmann W; Gehr B; Liebl A
    J Diabetes Sci Technol; 2019 Nov; 13(6):1158-1160. PubMed ID: 31195815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin delivery by implantable pumps.
    Zoltobrocki M
    Horm Metab Res Suppl; 1992; 26():140-5. PubMed ID: 1490683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assessment of intraperitoneal drug distribution during intraperitoneal chemotherapy using saline-injected MR imaging through an implanted catheter-port system].
    Obuchi M; Shimizu A; Fujiwara T; Sugimoto H; Honda M; Kubota H; Yamamoto W; Kinebuchi Y
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1891-5. PubMed ID: 11729482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of abdominal location of the catheter on the efficacy of intraperitoneal insulin infusion using implantable and programmable pumps in type I diabetes.
    Pinget M; Jeandidier N; Keipes M; Louy S; Vetter A
    Transplant Proc; 1992 Jun; 24(3):945-6. PubMed ID: 1604676
    [No Abstract]   [Full Text] [Related]  

  • 8. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment].
    Mozdzan M; Ruxer J; Loba J
    Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
    Jarosz-Chobot P
    Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin pump therapy. Situations and solutions.
    Lavin-Tompkins J
    Lippincotts Prim Care Pract; 1997; 1(5):519-26. PubMed ID: 9384140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
    Szypowska A; Pańkowska E; Lipka M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
    Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
    Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of an integrated sideport for diagnosis and management of decreased flow rates in a programmable implanted insulin delivery system. Implantable Insulin Pump Trial Study Group.
    Scavini M; Reich S; Eaton RP; Charles MA; Dunn FL
    Artif Organs; 1996 Sep; 20(9):991-6. PubMed ID: 8864020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2009 resource guide. Insulin pumps. Some people with diabetes use wearable pumps to provide their insulin.
    Diabetes Forecast; 2009 Jan; 62(1):49-52. PubMed ID: 19445086
    [No Abstract]   [Full Text] [Related]  

  • 15. Insulin-delivery devices.
    Hicks D
    Prof Nurse; 2003 Feb; 18(6):315-6. PubMed ID: 12630241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninjectable methods of insulin administration.
    Cernea S; Raz I
    Timely Top Med Cardiovasc Dis; 2006 Nov; 10():E29. PubMed ID: 17136235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing an implantable intraspinal drug delivery device in the ewe.
    Coombs DW; Colburn RW; DeLeo JA; Twitchell BB
    Reg Anesth; 1993; 18(4):230-7. PubMed ID: 8398957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dawning of a new age. The implantable insulin pump.
    Robinson LK
    Physician Assist; 1993 Apr; 17(4):91-2, 95-6, 98. PubMed ID: 10125680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.